NMDA (short for N-methyl-D-aspartate) receptor antagonists are a class of drugs that may help treat Alzheimer's disease, which causes memory loss, brain damage, and, eventually, death.There's no ...

More information: Sergio Escamilla et al, Synaptic and extrasynaptic distribution of NMDA receptors in the cortex of Alzheimer's disease patients, Alzheimer's & Dementia (2024). DOI: 10.1002/alz.14125 ...

In this study, recently published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association, the authors investigated NMDA receptors due to their importance in synaptic transmission ...

Sage had 338 full-time employees, all of whom will be laid off effective Aug. 22. The layoffs were announced a few weeks ...

Innovative protocol maps NMDA receptors in Alzheimer's-Affected brains. Universidad Miguel Hernandez de Elche. Funder Fondo de Investigaciones Sanitarias, Direcció General de Ciència i ...

Rivastigimine (Exelon) . Rivastigmine is used for mild to moderate Alzheimer’s disease. In patch form, it’s approved for severe Alzheimer’s. You take this twice a day as a capsule you swallow.

One Phase 3 test of Auvelity met its main goal in Alzheimer’s agitation while the drug’s other pivotal trial showed numerical improvement that fell short of statistical significance. Axsome ...

NMDA receptor antagonists work by regulating the activity of glutamate, another neurotransmitter that can be overactive in Alzheimer’s disease. This helps prevent excessive neuronal damage and ...

NMDA receptor antagonists, like memantine (Namenda), help manage Alzheimer’s by controlling glutamate activity in the brain. This protects brain cells from too much stimulation. Memantine can ...

More information: Sergio Escamilla et al, Synaptic and extrasynaptic distribution of NMDA receptors in the cortex of Alzheimer's disease patients, Alzheimer's & Dementia (2024). DOI: 10.1002/alz.14125 ...